Factors | No. of patients | Progression-free survival (PFS) | Overall survival (OS) | ||
---|---|---|---|---|---|
2-year PFS rate (%) | P value | 2-year OS rate (%) | P value | ||
Age | |||||
<53 years old | 81 | 40 | 0.13 | 47 | 0.30 |
≧53 years old | 81 | 46 | 56 | ||
Clinical 7th AJCC stage | |||||
IVA | 80 | 46 | 0.62 | 58 | 0.30 |
IVB | 82 | 41 | 45 | ||
Clinical T classification | |||||
T1 ~ 4a | 92 | 44 | 0.77 | 55 | 0.49 |
T4b | 70 | 42 | 46 | ||
Clinical N classification | |||||
N0/1 | 48 | 60 | 0.012* | 69 | 0.003* |
N2/3 | 114 | 36 | 44 | ||
Primary tumor site | |||||
Oral cavity | 62 | 39 | 0.19 | 44 | 0.18 |
Others | 100 | 46 | 56 | ||
Primary tumor site | |||||
Oropharynx | 60 | 45 | 0.65 | 55 | 0.42 |
Others | 102 | 42 | 49 | ||
Primary tumor site | |||||
Hypopharynx/Larynx | 36 | 50 | 0.28 | 61 | 0.36 |
Others | 126 | 41 | 48 | ||
Alcohol | |||||
Absent | 16 | 56 | 0.25 | 69 | 0.29 |
Present | 146 | 42 | 49 | ||
Betel nut chewing | |||||
Absent | 31 | 67 | 0.004* | 71 | 0.017* |
Present | 131 | 37 | 47 |